Literature DB >> 29425494

Crosstalk between the RNA Methylation and Histone-Binding Activities of MePCE Regulates P-TEFb Activation on Chromatin.

Samantha B Shelton1, Nakul M Shah1, Nathan S Abell2, Sravan K Devanathan1, Marvin Mercado1, Blerta Xhemalçe3.   

Abstract

RNAP II switching from the paused to the productive transcription elongation state is a pivotal regulatory step that requires specific phosphorylations catalyzed by the P-TEFb kinase. Nucleosolic P-TEFb activity is inhibited by its interaction with the ribonuclear protein complex built around the 7SK small nuclear RNA (7SK snRNP). MePCE is the RNA methyltransferase that methylates and stabilizes 7SK in the nucleosol. Here, we report that MePCE also binds chromatin through the histone H4 tail to serve as a P-TEFb activator at specific genes important for cellular identity. Notably, this histone binding abolishes MePCE's RNA methyltransferase activity toward 7SK, which explains why MePCE-bound P-TEFb on chromatin may not be associated with the full 7SK snRNP and is competent for RNAP II activation. Overall, our results suggest that crosstalk between the histone-binding and RNA methylation activities of MePCE regulates P-TEFb activation on chromatin in a 7SK- and Brd4-independent manner.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7SK; BCDIN3; MePCE; RNA methyltransferase; RNAP II pausing; chromatin; histones; non-coding RNA; pTEFb

Mesh:

Substances:

Year:  2018        PMID: 29425494     DOI: 10.1016/j.celrep.2018.01.028

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  12 in total

1.  Stabilize and connect: the role of LARP7 in nuclear non-coding RNA metabolism.

Authors:  Daniele Hasler; Gunter Meister; Utz Fischer
Journal:  RNA Biol       Date:  2020-06-03       Impact factor: 4.652

Review 2.  Role of RNA modifications in cancer.

Authors:  Isaia Barbieri; Tony Kouzarides
Journal:  Nat Rev Cancer       Date:  2020-04-16       Impact factor: 60.716

Review 3.  RNA-modifying proteins as anticancer drug targets.

Authors:  P Ann Boriack-Sjodin; Scott Ribich; Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2018-05-18       Impact factor: 84.694

Review 4.  RNA-modifying enzymes and their function in a chromatin context.

Authors:  Konstantinos Tzelepis; Oliver Rausch; Tony Kouzarides
Journal:  Nat Struct Mol Biol       Date:  2019-10-03       Impact factor: 18.361

5.  de novo MEPCE nonsense variant associated with a neurodevelopmental disorder causes disintegration of 7SK snRNP and enhanced RNA polymerase II activation.

Authors:  Pauline E Schneeberger; Tatjana Bierhals; Axel Neu; Maja Hempel; Kerstin Kutsche
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

6.  BCDIN3D regulates tRNAHis 3' fragment processing.

Authors:  Calder W Reinsborough; Hélène Ipas; Nathan S Abell; Ryan M Nottingham; Jun Yao; Sravan K Devanathan; Samantha B Shelton; Alan M Lambowitz; Blerta Xhemalçe
Journal:  PLoS Genet       Date:  2019-07-22       Impact factor: 5.917

7.  HEXIM1 Diffusion in the Nucleus Is Regulated by Its Interactions with Both 7SK and P-TEFb.

Authors:  Alessandro Furlan; Mariano Gonzalez-Pisfil; Aymeric Leray; Dorian Champelovier; Mélanie Henry; Corentin Le Nézet; Oliver Bensaude; Marc Lefranc; Thorsten Wohland; Bernard Vandenbunder; Gabriel Bidaux; Laurent Héliot
Journal:  Biophys J       Date:  2019-09-20       Impact factor: 4.033

8.  Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3.

Authors:  Ping Wang; Yangxi Deng; Yingjie Guo; Zuo Xu; Yiwen Li; Xiaowen Ou; Li Xie; Manjiao Lu; Jiayi Zhong; Bolin Li; Li Hu; Shenyu Deng; Tao Peng; Mingsheng Cai; Meili Li
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

9.  Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression.

Authors:  Morenci Manning; Yuanyuan Jiang; Rui Wang; Lanxin Liu; Shomita Rode; Madison Bonahoom; Seongho Kim; Zeng-Quan Yang
Journal:  RNA Biol       Date:  2020-01-19       Impact factor: 4.652

10.  JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes.

Authors:  Schuyler Lee; Haolin Liu; Ryan Hill; Chunjing Chen; Xia Hong; Fran Crawford; Molly Kingsley; Qianqian Zhang; Xinjian Liu; Zhongzhou Chen; Andreas Lengeling; Kathrin Maria Bernt; Philippa Marrack; John Kappler; Qiang Zhou; Chuan-Yuan Li; Yuhua Xue; Kirk Hansen; Gongyi Zhang
Journal:  Elife       Date:  2020-02-12       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.